1027477-16-2Relevant academic research and scientific papers
Synthesis and structure-activity relationship of a new series of COX-2 selective inhibitors: 1,5-Diarylimidazoles
Almansa, Carmen,Alfón, José,De Arriba, Alberto F.,Cavalcanti, Fernando L.,Escamilla, Ignasi,Gómez, Luis A.,Miralles, Agustí,Soliva, Robert,Bartrolí, Javier,Carceller, Elena,Merlos, Manuel,García-Rafanell, Julián
, p. 3463 - 3475 (2007/10/03)
The synthesis and the pharmacological activity of a series of 1,5-diarylimidazoles developed as potent and selective cyclooxygenase-2 (COX-2) inhibitors are described. The new compounds were evaluated both in vitro (COX-1 and COX-2 inhibition in human whole blood) and in vivo (carrageenan-induced paw edema, air-pouch, and hyperalgesia tests). Modification of all the positions of two regioisomeric imidazole cores led to the identification of 4-[4-chloro-5-(3-fluoro4-methoxyphenyl)imidazol-1-yl]benzenesulfonamide (UR-8880, 51f) as the best candidate, which is now undergoing Phase I clinical trials.
